The COVID-19 facemask: Friend or foe?

被引:1
|
作者
Hallock, Geoffrey G. [1 ]
机构
[1] St Lukes Hosp, Div Plast Surg, Sacred Heart Campus, Allentown, PA 18104 USA
关键词
D O I
10.1016/j.bjps.2020.12.034
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:1149 / 1150
页数:2
相关论文
共 50 条
  • [31] Friend or Foe - The Potential Mechanisms of Nicotine's Protective Role in COVID-19
    Lin, Mosi
    Zefi, Sidorela
    Zhao, Warren
    Ashby, Charles
    Mantell, Lin
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2023, 208 : S89 - S89
  • [32] Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) - friend or foe?
    Lewandowski, Konrad
    Kaniewska, Magdalena
    Rosolowski, Mariusz
    Tworek, Adam
    Rydzewska, Grazyna
    [J]. GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2022, 17 (03): : 219 - 226
  • [33] Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
    Mehta, Puja
    Chambers, Rachel C.
    Dagna, Lorenzo
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (06): : E394 - E395
  • [34] From Foe to Friend in COVID-19: Renin-Angiotensin System Inhibitors
    Kidde, Jason
    Sahebkar, Amirhossein
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (01): : 174 - 175
  • [35] Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
    Badagliacca, Roberto
    Sciomer, Susanna
    Petrosillo, Nicola
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (07): : 729 - 730
  • [36] SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?
    Scheen, A. J.
    [J]. DIABETES & METABOLISM, 2020, 46 (05) : 343 - 344
  • [37] Baricitinib as Treatment for Coronavirus Disease 2019 (COVID-19): Friend or Foe of the Pancreas?
    Cerda-Contreras, Christopher
    Nuzzolo-Shihadeh, Laura
    Camacho-Ortiz, Adrian
    Perez-Alba, Eduardo
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E3977 - E3978
  • [38] Nationwide practice on awake prone positioning for COVID-19 patients: 'a friend or foe?'
    Wilkinson, D.
    West, R.
    [J]. ANAESTHESIA, 2021, 76 : 92 - 92
  • [39] Ivermectin in the treatment of COVID-19-friend or foe?
    Schellack, N.
    Padayachee, N.
    Schellack, G.
    [J]. SA PHARMACEUTICAL JOURNAL, 2021, 88 (01) : 11 - +
  • [40] Renin-angiotensin system inhibition in COVID-19 patients: Friend or foe? Comment
    Karadag, Bilgehan
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 24 (01): : 30 - 31